Other languages Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Market Closed - OTC Markets Other stock markets 02:57:09 2024-06-03 pm EDT			5-day change	1st Jan Change
0.0036 ^USD	-34.55%		-.--%	-96.90%

Jul. 02	Innoveren Scientific Inc. Announces Resignation of William Horne as Member of the Board of Directors	CI
Jun. 04	Innoveren Scientific Inc. announced that it has received $0.25 million in funding	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Innoveren Scientific Inc. Announces Resignation of William Horne as Member of the Board of Directors	Jul. 02
Innoveren Scientific Announces 510(K) Submission to U.S. Federal Food and Drug Administration for Skindisc(Tm) Lite	Mar. 06
Innoveren Scientific Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 15
Innoveren Scientific Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	Nov. 15
Innoveren Scientific Inc. has Changed its Ticker to IVRN from HCYT	23-07-10
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-05-10
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	23-05-09
H-CYTE, Inc. (OTCQB: HCYT) completed the acquisition of SkinDisc from Tanya Rhodes, Brock Liden, Spencer T Brown and Spencer T Brown.	22-12-28
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14
H-CYTE, Inc. cancelled the acquisition of Catheter Precision, Inc.	22-09-07
H-CYTE, Inc. acquired Jantibody, LLC.	22-09-07
H-CYTE, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-12
H-Cyte, Inc. Closes Its Clinic in Scottsdale, Arizona	22-06-09
H-CYTE, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-04
H-CYTE, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-25
H-CYTE, Inc. Auditor Raises 'Going Concern' Doubt	22-02-24
H-CYTE, Inc. Appoints Richard Rosenblum and Matthew Anderer as Directors	22-01-14
H-CYTE, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-12
H-Cyte, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-13

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Innoveren Scientific Inc.

Equities

IVRN

US4041243076

Other languages

Filters